Back
Kiniksa Pharmaceuticals International PLC 10K Form
Sell
41
KNSA
Kiniksa Pharmaceuticals International PLC
Last Price:
21.16
Seasonality Move:
39.39%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive KNSA News And Ratings
See the #1 stock for the next 7 days that we like better than KNSA
KNSA Financial Statistics
Sales & Book Value
Annual Sales: | $270.26M |
---|---|
Cash Flow: | $-2.24M |
Price / Cash Flow: | 140.96 |
Annual Sales: | $6.06 |
Price / Book: | 3.55 |
Profitability
EPS (TTM): | -0.14000 |
---|---|
Net Income (TTM): | $-9.07M |
Gross Margin: | $236.85M |
Return on Equity: | -2.11% |
Return on Assets: | -1.73% |
Kiniksa Pharmaceuticals International PLC Earnings Forecast
Key Kiniksa Pharmaceuticals International PLC Financial Ratios
- The Gross Profit Margin over the past 5 years for KNSA is 87.64%.
- The Selling, General & Administrative Expenses for KNSA have been equal to 47.89% of Gross Profit Margin.
- The Research & Development expenses have been 28.16% of Revenue.
- The Net Earning history of KNSA is 5.21% of Total Revenues.
- Per Share Earnings over the last 8 years have been positive in 4 years.
Kiniksa Pharmaceuticals International PLC Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | KNSA |
CUSIP: | G5269C |
Website: | kiniksa.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 3.24 |
Quick Ratio: | 2.59 |
Price-to-Earnings
Trailing P/E Ratio: | 107.5 |
---|---|
Forward P/E Ratio: | 31.46 |
KNSA Technical Analysis vs Fundamental Analysis
Sell
41
Kiniksa Pharmaceuticals International PLC (KNSA)
is a Sell
Is Kiniksa Pharmaceuticals International PLC a Buy or a Sell?
-
Kiniksa Pharmaceuticals International PLC stock is rated a Sell
The current Kiniksa Pharmaceuticals International PLC [KNSA] share price is $21.21. The Score for KNSA is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.